Integrating Public Health Concerns into Patent Legislation in Developing Countries
(2000; 140 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoTHE SOUTH CENTRE
Ver el documentoFOREWORD
Ver el documentoACKNOWLEDGEMENTS
Ver el documentoGLOSSARY*
Abrir esta carpeta y ver su contenidoI. INTRODUCTION
Abrir esta carpeta y ver su contenidoII. PATENTABLE SUBJECT MATTER
Cerrar esta carpetaIII. SCOPE OF CLAIMS
Ver el documentoIII.1 Options - Scope of Claims
Abrir esta carpeta y ver su contenidoIV. PATENTABILITY REQUIREMENTS
Abrir esta carpeta y ver su contenidoV. SPECIAL CASES IN PHARMACEUTICALS
Abrir esta carpeta y ver su contenidoVI. DISCLOSURE
Abrir esta carpeta y ver su contenidoVII. EXCEPTIONS TO EXCLUSIVE RIGHTS
Abrir esta carpeta y ver su contenidoVIII. EXAMINATION AND OBSERVATION PROCEDURES
Abrir esta carpeta y ver su contenidoIX. CLAIMS INTERPRETATION
Abrir esta carpeta y ver su contenidoX. COMPULSORY LICENSING
Ver el documentoXI. FINAL REMARKS
Ver el documentoREFERENCES
Ver el documentoBACK COVER
 

III.1 Options - Scope of Claims

Several elements may be included in national laws to deal with the issue of the scope of claims. If a country wishes to ensure that the scope of protection is defined as precisely as possible, on the basis of structurally defined claims, it may follow Option 1.

Option 1 would not allow for claims defined solely on the basis of the function that an invention performs, nor the definition of a product through the process for obtaining it.

If, however, a country wished to establish a broader scope of patenting, option 2 would be preferable, since it would permit the granting of patents even if claims are defined in non-structural terms and also “product-by-process claims” but, in this latter case, only in relation to the product that is “obtained” (not “obtainable”) with the process.

Scope of Claims
Model Options

1. The claims of a patent shall define the invention for which protection is sought in terms of its purpose, constitution and effects. A claim which only recites the operation and effects of an invention shall not be accepted. A product claim shall not be admitted if the product is not sufficiently defined as such.

2. Product-by-process claims shall be accepted only when a structural description of the invention is not possible. The protection shall be limited in these cases to the product obtained with the claimed process.

It also may be possible to combine the first part of Option 1 with Option 2, or consider other alternatives.

Policy makers should recognize that, while health-related inventions may require special attention, the rules adopted will apply to all fields of technology, and that the personnel of the Patent Office should be well trained in order to adequately apply the provisions on this matter.

 

Ir a la sección anterior
Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019